These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32505571)

  • 21. Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer.
    Pennarun B; Meijer A; de Vries EG; Kleibeuker JH; Kruyt F; de Jong S
    Biochim Biophys Acta; 2010 Apr; 1805(2):123-40. PubMed ID: 19961901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane expression of DR4, DR5 and caspase-8 levels, but not Mcl-1, determine sensitivity of human myeloma cells to Apo2L/TRAIL.
    Gómez-Benito M; Martinez-Lorenzo MJ; Anel A; Marzo I; Naval J
    Exp Cell Res; 2007 Jul; 313(11):2378-88. PubMed ID: 17462628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancement of Apo2L/TRAIL-mediated cytotoxicity in esophageal cancer cells by cisplatin.
    Tsai WS; Yeow WS; Chua A; Reddy RM; Nguyen DM; Schrump DS; Nguyen DM
    Mol Cancer Ther; 2006 Dec; 5(12):2977-90. PubMed ID: 17172403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular requirements for the combined effects of TRAIL and ionising radiation.
    Marini P; Jendrossek V; Durand E; Gruber C; Budach W; Belka C
    Radiother Oncol; 2003 Aug; 68(2):189-98. PubMed ID: 12972315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation.
    Baritaki S; Katsman A; Chatterjee D; Yeung KC; Spandidos DA; Bonavida B
    J Immunol; 2007 Oct; 179(8):5441-53. PubMed ID: 17911631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor-related apoptosis inducing ligand (TRAIL) up-regulates death receptor 5 (DR5) mediated by NFkappaB activation in epithelial derived cell lines.
    Shetty S; Gladden JB; Henson ES; Hu X; Villanueva J; Haney N; Gibson SB
    Apoptosis; 2002 Oct; 7(5):413-20. PubMed ID: 12207174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRAIL apoptosis is enhanced by quercetin through Akt dephosphorylation.
    Kim YH; Lee YJ
    J Cell Biochem; 2007 Mar; 100(4):998-1009. PubMed ID: 17031854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
    Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
    J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.
    Harper N; Hughes MA; Farrow SN; Cohen GM; MacFarlane M
    J Biol Chem; 2003 Nov; 278(45):44338-47. PubMed ID: 12920112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts.
    Psahoulia FH; Drosopoulos KG; Doubravska L; Andera L; Pintzas A
    Mol Cancer Ther; 2007 Sep; 6(9):2591-9. PubMed ID: 17876056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APE1-mediated DNA damage repair provides survival advantage for esophageal adenocarcinoma cells in response to acidic bile salts.
    Hong J; Chen Z; Peng D; Zaika A; Revetta F; Washington MK; Belkhiri A; El-Rifai W
    Oncotarget; 2016 Mar; 7(13):16688-702. PubMed ID: 26934647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective inhibition of FLICE-like inhibitory protein expression with small interfering RNA oligonucleotides is sufficient to sensitize tumor cells for TRAIL-induced apoptosis.
    Siegmund D; Hadwiger P; Pfizenmaier K; Vornlocher HP; Wajant H
    Mol Med; 2002 Nov; 8(11):725-32. PubMed ID: 12520089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-specific apoptotic gene targeting overcomes radiation resistance in esophageal adenocarcinoma.
    Chang JY; Zhang X; Komaki R; Cheung R; Fang B
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1482-94. PubMed ID: 16580499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TNF antagonizes CCN1 in apoptosis in esophageal adenocarcinoma.
    Dang T; Chang Z; Meng J; Cui X; Wang P; Chai J
    Cytokine; 2022 Jan; 149():155728. PubMed ID: 34634651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low glucose-enhanced TRAIL cytotoxicity is mediated through the ceramide-Akt-FLIP pathway.
    Nam SY; Amoscato AA; Lee YJ
    Oncogene; 2002 Jan; 21(3):337-46. PubMed ID: 11821946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Song JH; Bellail A; Tse MC; Yong VW; Hao C
    J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of DNA damage in Barrett's esophageal cells exposed to acidic bile salts.
    Bhardwaj V; Horvat A; Korolkova O; Washington MK; El-Rifai W; Dikalov SI; Zaika AI
    Carcinogenesis; 2016 Dec; 37(12):1161-1169. PubMed ID: 27655834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular determinants of response to TRAIL in killing of normal and cancer cells.
    Kim K; Fisher MJ; Xu SQ; el-Deiry WS
    Clin Cancer Res; 2000 Feb; 6(2):335-46. PubMed ID: 10690508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.